Özet:

Summary: Periferic lymph nodus or thin injection aspiration (IA) has been shown by previous studies that it is a non-invasive method of examination and provides cytopathological diagnosis. Here we aimed to emphasize the contribution to the diagnosis and evolution of cancer of non-aspiration thin injection, not thin injection aspiration with the traditional absorption force application. In 10 cases with a mass in the lungs, the results of AIS applied to the peripheral lymph nodes or peripheral masses in the lungs were evaluated. The average age of the ten patients (1 of the women 9 of the men) was 59 (35-84) years. 7 patients with peripheral lymphatic nodes and 3 patients with peripheral plain lymphatic injury were diagnosed and spreads were assessed. 2 of 10 patients with AIS from the peripheral lymph nodes and peripheral mass were diagnosed with squamotic cell cancer, 4 with noncellular lung cancer, and 4 with malignity positively. 2 of the 4 patients diagnosed malignity positively with a bronchoscope and scamotic cell carcinoma and small cell carcinoma were diagnosed, while 2 were diagnosed with scamotic cell carcinoma and lymphoma with a trucut biopsy. In addition to the diagnosis of AIS from the lymphatic nodes and peripheral lesions, it has also been beneficial in terms of evolution in lung cancer patients. As a result, AI is an easy and effective method for patients with peripheral tumor or tumor metastasis. In addition to the diagnosis, it is also useful in the assessment of tumor non-receptability and other distinguishing diagnoses. Therefore, the start of the non-invasive diagnosis method may be in patients who are suitable for HIV injury and are at risk in terms of invasive processes. It is possible to increase the diagnosis with sitoblok methods. Keywords: Aspirationless thin ink cytology, peripheral lymph nod, peripheral lymph injury Abstract: Fine needle aspiration (FNA) for peripheral lymph nod or injury was shown a non-invasive method that provides cytopathologic diagnosis with previous studies. We aimed to emphasize the contribution of fine needle nonaspiration cytology (FNNAC) not FNA performed by traditional suction force in diagnosis and staging of cancer. The results of FNNAC performed to the peripheral lymph nodes and lesions were evaluated in 10 cases with pulmonary mass. The average age of 10 patients (1 was female, 9 were male) was 59 (35-84) years old. FNNAC was performed 7 of patients with peripheral lymph nodes, 3 of patients with peripheral lesion and, slides were evaluated. FNNAC was performed in 10 patients who 2 were diagnosed as squamous cell carcinoma (SQCLC), 4 were diagnosed as nonsmall cell lung carcinoma and 4 were diagnosed as positive malignancy. Two of 4 patients with positive malignancy were diagnosed as SQCLC and small cell carcinoma with bronchoscopy, while the other 2 were diagnosed as SQCLC and lymphoma with trucut biopsy. FNNAC performed on peripheral lymph nodes and lesions has provided benefits in terms of staging while confirmed the diagnosis. FNNAC is a simple and reliable method in patients whose tumors or tumor metastasis are available peripherally; in addition to tumor diagnosis it may be helpful for the evaluation of non-resectability and other differential diagnosis. FNNAC can be initial non-invasive diagnostic method especially in appropiate lesions and in patients with risk factors for invasive process. It might be possible to increase the diagnosis with cytobloc methods. Keywords: fine needle nonaspiration cytology, peripheral lymph nodes, peripheral lung lesion

Anahtar Kelimeler: